GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » DA32 Life Science Tech Acquisition Corp (NAS:DALS) » Definitions » EV-to-EBITDA

DA32 Life Science Tech Acquisition (DA32 Life Science Tech Acquisition) EV-to-EBITDA : -143.78 (As of May. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is DA32 Life Science Tech Acquisition EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, DA32 Life Science Tech Acquisition's enterprise value is $264.40 Mil. DA32 Life Science Tech Acquisition's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 was $-1.84 Mil. Therefore, DA32 Life Science Tech Acquisition's EV-to-EBITDA for today is -143.78.

The historical rank and industry rank for DA32 Life Science Tech Acquisition's EV-to-EBITDA or its related term are showing as below:

DALS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -927.11   Med: 0   Max: 0
Current: -143.78
DALS's EV-to-EBITDA is not ranked
in the Diversified Financial Services industry.
Industry Median: 8.895 vs DALS: -143.78

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-20), DA32 Life Science Tech Acquisition's stock price is $10.32. DA32 Life Science Tech Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 was $0.070. Therefore, DA32 Life Science Tech Acquisition's PE Ratio for today is 147.43.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

DA32 Life Science Tech Acquisition EV-to-EBITDA Historical Data

The historical data trend for DA32 Life Science Tech Acquisition's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DA32 Life Science Tech Acquisition EV-to-EBITDA Chart

DA32 Life Science Tech Acquisition Annual Data
Trend Dec21 Dec22
EV-to-EBITDA
- -145.27

DA32 Life Science Tech Acquisition Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EV-to-EBITDA Get a 7-Day Free Trial -279.44 -165.19 -151.19 -145.27 -140.99

Competitive Comparison of DA32 Life Science Tech Acquisition's EV-to-EBITDA

For the Shell Companies subindustry, DA32 Life Science Tech Acquisition's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DA32 Life Science Tech Acquisition's EV-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, DA32 Life Science Tech Acquisition's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where DA32 Life Science Tech Acquisition's EV-to-EBITDA falls into.


DA32 Life Science Tech Acquisition EV-to-EBITDA Calculation

DA32 Life Science Tech Acquisition's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=264.404/-1.839
=-143.78

DA32 Life Science Tech Acquisition's current Enterprise Value is $264.40 Mil.
DA32 Life Science Tech Acquisition's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DA32 Life Science Tech Acquisition  (NAS:DALS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

DA32 Life Science Tech Acquisition's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10.32/0.070
=147.43

DA32 Life Science Tech Acquisition's share price for today is $10.32.
DA32 Life Science Tech Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.070.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

DA32 Life Science Tech Acquisition EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of DA32 Life Science Tech Acquisition's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

DA32 Life Science Tech Acquisition (DA32 Life Science Tech Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » DA32 Life Science Tech Acquisition Corp (NAS:DALS) » Definitions » EV-to-EBITDA
Comparable Companies
GTAC FHLT SHAP QFTA SRSA PRLH CRZN TCAC OPA VHNA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
345 Park Avenue South, 12th Floor, New York, NY, USA, 10010
Website
DA32 Life Science Tech Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Da32 Sponsor Llc 10 percent owner 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Management Company, L.p. (series C) director, 10 percent owner, other: Director by deputization 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Arch Venture Fund Xi, L.p. 10 percent owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631
Section 32 Fund 3, Lp 10 percent owner, other: Director by Deputization 169 UNIVERSITY AVE., PALO ALTO CA 94301
Keith Crandell director, 10 percent owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631
William J Maris 10 percent owner, other: Director by Deputization 2033 SAN ELIJO AVE., #565, CARDIFF-BY-THE-SEA CA 92007
Angela Lai director 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Arch Venture Partners Xi, Llc 10 percent owner 8755 W HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631
Arch Venture Partners Xi, L.p. 10 percent owner 8755 W HIGGINS RD., SUITE 1025, CHICAGO IL 60631
Section 32 Gp 3, Llc 10 percent owner, other: Director by Deputization 171 MAIN STREET, #671, LOS ALTOS CA 94022
Steven J. Kafka director, officer: Chief Executive Officer C/O FOUNDATION MEDICINE, INC., ONE KENDALL SQUARE, SUITE B3501, CAMBRIDGE MA 02139
Andrew Elbardissi director 2210 FARADAY AVE #100, CARLSBAD CA 92008
Chris Wolfe officer: Chief Financial Officer 230 PARK AVENUE SOUTH, 11TH FLOOR, C/O CAPITAL Z PARTNERS, NEW YORK NY 10003
Kristina Burow 10 percent owner 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631
Mara G. Aspinall director 7381 NORTH MOON SPIRIT LANE, TUCSON AZ 85718